免疫固定电泳与游离轻链检测在AL淀粉样变性中的诊断价值:系统评价与荟萃分析
该系统评价与荟萃分析检索了PubMed、Embase和CENTRAL数据库(截至2024年3月),纳入44项研究(n=18 071),评估血清免疫固定电泳(SIFE)、尿免疫固定电泳(UIFE)和血清游离轻链(sFLC)比值检测AL淀粉样变性相关浆细胞病的敏感性。汇总敏感性分别为SIFE 0.68、UIFE 0.77、SIFE联合UIFE 0.89、sFLC比值0.82,三者联合敏感性达0.99,支持其作为初始检测策略。
要点
- SIFE单独敏感性0.68,UIFE单独0.77,SIFE联合UIFE为0.89。
- sFLC比值单独敏感性0.82,三者联合敏感性达0.99。
- 推荐联合SIFE、UIFE和sFLC比值作为AL淀粉样变性的初始筛查策略。
核心结论
- 联合SIFE、UIFE和sFLC比值检测对AL淀粉样变性相关浆细胞病具有高敏感性,可作为可靠的初始检测策略。
研究设计与样本
- 系统评价与荟萃分析,检索PubMed、Embase和CENTRAL数据库自建库至2024年3月,最终纳入44项研究(n=18 071)。
- 采用GRADE评估证据确定性,QUADAS-2评估偏倚风险。
主要发现
- SIFE汇总敏感性0.68(95%CI 0.62-0.73),基于28项研究(n=3390)。
- UIFE汇总敏感性0.77(95%CI 0.72-0.81),基于24项研究(n=2830)。
- SIFE联合UIFE汇总敏感性0.89(95%CI 0.84-0.93),基于19项研究(n=2819)。
- sFLC比值汇总敏感性0.82(95%CI 0.78-0.86),基于21项研究(n=3678)。
- SIFE、UIFE和sFLC比值三者联合汇总敏感性0.99(95%CI 0.96-1.00),基于10项研究(n=1430)。
关键数值与推荐
- SIFE单独敏感性0.68(95%CI 0.62-0.73)。
- UIFE单独敏感性0.77(95%CI 0.72-0.81)。
- SIFE联合UIFE敏感性0.89(95%CI 0.84-0.93)。
- sFLC比值敏感性0.82(95%CI 0.78-0.86)。
- 三者联合敏感性0.99(95%CI 0.96-1.00)。
临床怎么用
- 联合SIFE、UIFE和sFLC比值可作为AL淀粉样变性的初始检测策略,提高疑似病例的检出。
- 高敏感性结果有助于指导后续诊断检查的选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In this systematic review, we aimed to assess the sensitivity of serum immunofixation (SIFE), urine immunofixation (UIFE), and serum free light chain (sFLC) in detecting plasma cell dyscrasia associated with light chain (AL) amyloidosis. We searched the literature using PubMed, Embase, and CENTRAL databases since inception through March 2024. We included studies reporting the diagnostic accuracy of immunofixation and/or sFLC in patients with AL amyloidosis. We used the GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) approach to assess the certainty of the evidence and QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies-2) to assess the risk of bias. After deduplication, 29 237 records were screened, and 44 studies (n = 18 071) were included. For the meta-analysis, 28 studies reported sensitivity for SIFE (n = 3390), 24 studies for UIFE (n = 2830), 19 studies for SIFE and UIFE (n = 2819), 21 studies for sFLC ratio (n = 3678), 6 studies for SIFE and sFLC ratio (n = 372), 3 studies for UIFE and sFLC ratio (n = 242), and 10 studies for all 3 tests (n = 1430). Pooled sensitivities were as follows: SIFE, 0.68 (95% confidence interval [CI], 0.62-0.73); UIFE, 0.77 (95% CI, 0.72-0.81); SIFE and UIFE, 0.89 (95% CI, 0.84-0.93); and sFLC ratio, 0.82 (95% CI, 0.78-0.86). When SIFE, UIFE, and sFLC ratio were combined, the sensitivity reached 0.99 (95% CI, 0.96-1.00). The high sensitivity of combining SIFE, UIFE, and sFLC ratio supports their use as a reliable initial testing strategy to raise suspicion for AL amyloidosis and guide decisions regarding future diagnostic modalities.
引用
- Azzam M, Hamarsha Q, Kawtharany H, et al. Diagnostic utility of immunofixation and free light chain assay in AL amyloidosis: a systematic review and meta-analysis. Blood Adv. 2026. PMID: 41979328. doi:10.1182/bloodadvances.2025019530
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。